微创医疗科学有限公司2025年度报告

年 度 報 告2025 345671030356379878889919395 公司資料 PO Box 309, Ugland HouseGrand Cayman, KY1-1104Cayman Islands 1601201203 33191922 頴FCGHKFCGACGHKACG 頴FCGHKFCGACGHKACG 1831717121716 www.microport.com 00853.HK40168.HK 財務摘要 五年財務摘要 公司概況 ®20,000* 5® 12,000*® ®® 主席報告 38.4*123.569.1 78.8%163.9286.6%255.0% 2025MicroGenius®®Einstein®™84436NMPA534072FDAFirehawk®®(NEJM) 主席報告 20%182.211.1%FireSweeper®™FireSpear™™FireFeeler®FireSpear™®™NMPA 235.242025NEXUS®FDAEvolution®Evolution MPX™™FDACECloudrider™™NMPA 51.31.3%255.0%TAVI900350%AnchorMan®™CETAVI4,000AnchorMan®™360% )229.7207.00.7%FLEXIGO™ 3DFDACEVEGA™ MCE22.73.0TTEN™PLATINIUM™ 189.512.0%77.712.2%Tipspear®™FinderSphere®™NMPA56.5%19%50Hector®™FDA 主席報告 111.03.8%6.6730%Bridge®™ MAX39.4%13%142%APOLLO Dream®Dream®FDA 77.6114.2%1560.7%56.0286.6%®CE®UniPath™NMPA ® 管理層討論及分析 1,105.46.0% 38.4 123.5 1.760.59.0%10.363.1 管理層討論及分析 78.8%163.9 Hector®™APOLLODream®™(FDA)844 MicroGenius®®Einstein®™ 36NMPATomaHawk®®YINI®®UniPath®®53407IceMagic® 管理層討論及分析 Firehawk®®TARGET-FIRST2025(ESC 2025)NEJM2025 182.211.1%20% 142.118.9%7(i)52%30%FireFalcon®®(ii)120%Firelimus®®(iii)1.9+4 管理層討論及分析 Firehawk®®NEJMFireSweeper®™FireSpear ™™FireFeeler®FireSpear™®™NMPAFIMST 10.1%21%TCTESC EuroPCREMEAPCI PCI 235.24 管理層討論及分析 216.61.6%SkyWalker®®Evolution®NEXUS®FDAEvolution® 18.645.4%Evolution®MPX ™™FDACE MDR20263NMPACloudrider ™™ 管理層討論及分析 51.31.3%255.0%TAVI900350%AnchorMan®™CE(LAAC)AnchorMan®360%TAVI4,000 229.7207.00.7%(LBBAP)LBBAPFLEXIGO ™ 3DFDACEVEGA ™ M22.73.0TTEN ™(ICD)PLATINIUM ™ 管理層討論及分析 TAVI 189.512.0%77.712.2% Castor®™1,400Minos®™1,200Reewarm®PTX™ PTX1,400Talos®™Castor®Minos®Reewarm®PTX2,900Cratos®Tipspear®™FinderSphere®™NMPAHector®™Aegis®II™ 管理層討論及分析 56.5%19%75011291106CE3Castor®Minos®30Cratos®Talos®Hector®™20263FDA 111.03.8%0.573.5% 管理層討論及分析 6.6730%NUMEN®NUMEN®®NESTTubridge®Bridge®Bridge®™ MAX4.5/5.0mm243,800 39.4%13%142%NUMEN®X-track®EMEANUMEN®NeuroHawk®X-track®1736920263APOLLO Dream®Dream®FDA(ICAD) 286StraitPass®™ 管理層討論及分析 5G77.6114.2%3002001560.7% 56.0286.6%Toumai®®®80®22050140SkyWalker®®®65R-ONE®6 管理層討論及分析 ®4060®NMPAMOHAP(Cleveland Clinic Abu Dhabi)®NMPAFDACE20CE®UniPath ™NMPA ®MicroGenius®®88%AI®®NMPA1080020100%605G 管理層討論及分析 36NMPA84453407Hector®™APOLLO Dream®™ Dream®2FDA NMPAFirelimus®®TomaHawk®®3.0TMRITEN ™Cratos®™Tipspear®™Toumai®SP®SPToumai®®Sheathru ™™Cerelmon ™™NeuroHawk Medibox ™™Numen®NestYINI®®YairDent®®EZ-Eye ™™ 5100TACTIC®Antarctic ™®UniPath®® 250 109.2106.6% 管理層討論及分析 163.978.8%286.6%56.5%39.4%255.0% 6,5471,72226% &115 管理層討論及分析 12®®34 管理層討論及分析 6.0%7.2%53.1% 管理層討論及分析 1,105.41,031.17.2%6.0% 182.211.1%9.9% 235.27.5%6.9% 管理層討論及分析 229.74.1%(i)MRI(ii)6.1% 189.512.0%11.8%(i)(ii)56.5% 51.31.3%1.2%VitaFlow Liberty®Alwide®Plus2024255.0% 77.6114.2%115.4% 95.688.9%84.8% 111.03.8%(i)39.4%(ii) 管理層討論及分析 470.8457.03.0% 574.110.5%634.655.7%57.4% 216.532.3%146.5 304.24.6%318.1 176.64.0%169.6 55.029.4 106.44.8%111.5 87.922.1%107.3 管理層討論及分析 43.738.0 268.538.4EBITDA#60.4369.8 管理層討論及分析 682.5713.0(i)(ii)(iii) 1,549.31,597.147.868.5%59.4% 504.5558.3 8.412.3 101.8(i)(ii)(iii) 750.2(i)(ii) 董事會及高級管理層 35Endocare Inc.Cryomedical Sciences Inc.22522172 200363)(CPA)ACCAACCA300841)600619)600383) 20 董事會及高級管理層 30UTAC Holdings Ltd.Kulicke & Soffa IndustriesK&SKLIC)20152016K&SK&S21602252SeaTownAddVita Pte. Ltd.(Duke University, Fuqua School of Business)2013 22520053806600 董事會及高級管理層 Simmons & SimmonsSidley Austin600496)002403301230)688691LakeShore Biopharma Co., Ltd.LSB 13.51B(1) Jonathan W ChenChenChenChen29ChenAngiotechAngiotechChenCredit SuisseAlex. Brown &SonsChen 28 董事會及高級管理層 Brian Yale Chang10Chang17ChangPaul & Daisy Soros FellowshipSeidman Prize for Outstanding ThesisChang Benoit ClinchampsClinchamps26SorinLiva NovaSorinClinchampsGE Healthcare6ClinchampsICAM Lille France (InstitutCatholique des Arts et Métiers)ENSAE Toulouse France (Ecole Nationale Supérieure de l’Aéronautique et de l’Espace)TUM Germany (Technische Universitat München)INSEAD Fontainebleau France 28EMBA Firehawk®1853 董事會及高級管理層 26 20 1631002007620103 DePuy Ace Sarl 1210INSEAD He LiLiLiLi1416LiSauder 董事會報告 1,105.46.0%38.448.5 1029314 (EHS)EHS 董事會報告 31 董事會報告 1029 董事會報告 5.6%11.7%13.2%33.3% 5% 29(c) 751,908,000583,688,000 董事會報告 3034 8.10 78 C1E.1.5 1,0001,7505001,0000500 董事會報告 XVXV78352C3 (1)(2)(i)161,290(ii)6,300(3)Jonathan W Chen(i)5,637,360(ii)800,000 董事會報告 XVXV78352 XV23336 董事會報告 董事會報告 董事會報告 (1)We’Tron Capital Limited 100%We’Tron Capital Limited3,283,234 (2) (3)18.76%64.78%50%45.34% 2 (4)Shanghai Zhangjiang Scienceand Technology Investment Co.100%Shanghai Zhangjiang Science and Technology Investment Co.100%Shanghai ZJ Hi-Tech Investment Corporation50%Shanghai ZhangjiangHi-Tech Park Development Co., Ltd.50.75%Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd.Shanghai Zhangjiang Haocheng VentureCapital Co., Ltd.100%Shanghai Zhangjiang Haocheng Venture Capital Co., Ltd.Shanghai (Z.J.) H